36,61 However, exenatide ER is encapsulated in microspheres of medical-grade poly-(D,L-lactide-co-glycolide), which ensures the gradual and extended release of the drug (Figure 2B)
AT3274 and BR4873, respectively) on an Olympus AU640 (Olympus, Japan) according to manufacturer's protocol (24)
In contrast, GLP-2 is used as a therapy for intestinal injury and short bowel syndrome due to its effects of promoting mucosal epithelium expansion, and crypt cell proliferation and improving intestinal adaptation and nutrient absorption (2327)
Available from: Accessed on 25/09/2025
Using cloudy medication can lead to reduced effectiveness and a higher risk of injection site reactions
Novo Nordisk told Reuters it is now awaiting a court decision on a subsequent appeal